The regulation of HGF and TGF-beta by an angiotensin II type 1 receptor antagonist in hepatic ischemia-reperfusion injury.
Araya
J
J
Department of Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
Tsuruma
T
T
Hirata
K
K
Yagihashi
A
A
Meguro
M
M
Kawakami
M
M
Yanai
Y
Y
Watanabe
N
N
D057911:Angiotensin Receptor Antagonists; D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D005786:Gene Expression Regulation / Q000187:drug effects; D017228:Hepatocyte Growth Factor / Q000235:genetics / Q000502:physiology*; D008099:Liver / Q000473:pathology; D008102:Liver Circulation / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D044140:Receptor, Angiotensin, Type 1; D015427:Reperfusion Injury / Q000517:prevention & control*; D013777:Tetrazoles; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000502:physiology*
D057911:Angiotensin Receptor Antagonists; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles; D016212:Transforming Growth Factor beta; D017228:Hepatocyte Growth Factor; C077793:candesartan cilexetil